Active Research Grants
Current funded research projects supporting the Lee Lab’s work in cardiovascular metabolism, NAD+ biology, and translational therapeutic discovery.
Roles of SARM1 NAD+ Hydrolase in Metabolic Cardiomyopathy
Funding Source: NHLBI (1R01HL164854-01A1)
Role: Principal Investigator
Funding Period: June 2023 – May 2028
Development of a Cell-Based Screening Assay to Identify Novel SARM1 Inhibitors
Funding Source: Oklahoma Biotech Startup Program (OKBiostart), University of Oklahoma
Role: Principal Investigator
Funding Period: September 2023 – August 2024
Determine the Role of Activated SARM1 NAD+ Hydrolase in Heart Disease
Funding Source: PHF Technology Enabling Grant, Presbyterian Health Foundation
Role: Principal Investigator
Funding Period: July 2022 – June 2024